REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH): auditor change — Reviva Pharmaceuticals appoints Baker Tilly as new auditor after Moss Adams merger

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Moss Adams LLP merged with Baker Tilly US, LLP effective June 3, 2025; Moss Adams resigned as auditor the same day.
Audit Committee appointed Baker Tilly as successor independent registered public accounting firm effective June 3, 2025.
No disagreements or reportable events occurred with Moss Adams during fiscal years 2024-2025 interim period.
Prior audit reports included a going concern explanatory paragraph; no adverse or qualified opinions issued.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Moss Adams LLP resigned as auditor of REVIVA PHARMACEUTICALS HOLDINGS, INC..

Action: resignation
Auditor: Moss Adams LLP
Successor: Baker Tilly US, LLP

Exact text from the filing

On June 3, 2025, Reviva Pharmaceutical Holdings Inc., (the "Company") was notified that Moss Adams LLP ("Moss Adams"), the Company's independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices will operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company effective June 3, 2025, and the Audit Committee of the Company’s Board of Directors appointed Baker Tilly, as the successor to Moss Adams, as the Company’s new independent registered public accounting firm, also effective June 3, 2025.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

REVIVA PHARMACEUTICALS HOLDINGS, INC. engaged Baker Tilly US, LLP as its auditor.

Action: engagement
Auditor: Baker Tilly US, LLP

Exact text from the filing

the Audit Committee of the Company’s Board of Directors appointed Baker Tilly, as the successor to Moss Adams, as the Company’s new independent registered public accounting firm, also effective June 3, 2025.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

REVIVA PHARMACEUTICALS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-019716

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.